Ropinirole for the Treatment of Hyperprolactinemia: A Dose Escalation Study of Efficacy and Tolerability.

Liam J HeneghanAmanda TsangCara DiminoAlexander G KhandjiSunil Kumar PanigrahiGabrielle Page-Wilson

Published in: The Journal of clinical endocrinology and metabolism (2023)

These data demonstrate the efficacy and tolerability of ropinirole for the treatment of hyperprolactinemia in patients with microprolactinomas and idiopathic hyperprolactinemia and suggest ropinirole may represent a novel therapeutic alternative for treating hyperprolactinemic disorders in patients with ergot DA intolerance.

Keyphrases

open label
clinical trial
randomized controlled trial
electronic health record
big data
double blind
study protocol